4.7 Article

Disease progression modelling of Alzheimer's disease using probabilistic principal components analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Public, Environmental & Occupational Health

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease 2019

Emma Nichols et al.

Summary: With projected trends in population ageing and growth, the number of people with dementia is expected to increase. Understanding the distribution and magnitude of anticipated growth is crucial for public health planning and resource prioritization, with a focus on potentially modifiable risk factors.

LANCET PUBLIC HEALTH (2022)

Article Neurosciences

Robust parametric modeling of Alzheimer's disease progression

Mostafa Mehdipour Ghazi et al.

Summary: The study focuses on robust modeling of Alzheimer's disease progression using parametric methods, mapping individual age to a disease progression score (DPS) and fitting logistic functions to biomarkers. The proposed approach demonstrates good modeling performance and classification accuracy, outperforming previous state-of-the-art results in predicting biomarker values and clinical status classification. Additionally, the model trained on ADNI data generalizes well to NACC data with high accuracy.

NEUROIMAGE (2021)

Article Computer Science, Artificial Intelligence

Robust hybrid deep learning models for Alzheimer's progression detection

Tamer Abuhmed et al.

Summary: This study introduces two novel deep learning architectures for AD progression detection, one is an interpretable multitask regression model and the other is a hybrid model, both of which demonstrate effectiveness and practicality on ADNI data.

KNOWLEDGE-BASED SYSTEMS (2021)

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

Summary: Alzheimer's disease is projected to see a significant increase in prevalence in the future, with genetics playing a key role. Novel biomarkers and lifestyle-based prevention trials show promising therapeutic potential. Promising pharmacological treatments are advancing in clinical trials, targeting amyloid beta, tau, and inflammation.

LANCET (2021)

Article Multidisciplinary Sciences

Machine learning methods to predict amyloid positivity using domain scores from cognitive tests

Guogen Shan et al.

Summary: Amyloid-beta is the target in clinical trials for Alzheimer's disease, and using machine learning models based on easily accessible data to accurately predict A beta status can improve the effectiveness of trials. Different ML models are being developed for subpopulations stratified by sex and disease stages, using data from the AD Neuroimaging Initiative.

SCIENTIFIC REPORTS (2021)

Article Mathematical & Computational Biology

Simultaneous modeling of Alzheimer's disease progression via multiple cognitive scales

Line Kuhnel et al.

Summary: A new multivariate continuous-time disease progression (MCDP) model that accurately predicts future trajectories of Alzheimer's disease patients was proposed and evaluated using long-term follow-up data. Compared to previous models, this MCDP model showed superior predictive ability. Analysis of cognitive scales sensitivity revealed different item performances at various stages of the disease.

STATISTICS IN MEDICINE (2021)

Article Multidisciplinary Sciences

AD Course Map charts Alzheimer's disease progression

Igor Koval et al.

Summary: This paper introduces a spatiotemporal atlas called AD Course Map for Alzheimer's disease progression, highlighting strong genetic determinants for the progression and predicting patients' cognitive decline with better accuracy than other benchmarked methods. The map also offers new tools for exploring the progression of Alzheimer's disease and personalizing patients care through simulations of virtual patient cohorts.

SCIENTIFIC REPORTS (2021)

Article Clinical Neurology

Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET

Suzanne E. Schindler et al.

Summary: The study found that the tipping point in amyloid accumulation in the brain is strongly correlated with the age of symptom onset in Alzheimer's disease. By estimating the age at which an individual reaches this tipping point, the age of symptom onset can be predicted accurately.

NEUROLOGY (2021)

Review Health Care Sciences & Services

Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review

Sayantan Kumar et al.

Summary: In the past five years, there has been a significant increase in research using machine learning methods for AD dementia modeling, focusing on predicting the risk of progression. The studies predominantly utilize publicly available datasets containing neuroimaging and clinical data.

JAMIA OPEN (2021)

Article Computer Science, Information Systems

Statistical Disease Progression Modeling in Alzheimer Disease

Lars Lau Raket

FRONTIERS IN BIG DATA (2020)

Article Health Care Sciences & Services

Bayesian latent time joint mixed effect models for multicohort longitudinal data

Dan Li et al.

STATISTICAL METHODS IN MEDICAL RESEARCH (2019)

Article Neurosciences

Estimation of brain age delta from brain imaging

Stephen M. Smith et al.

NEUROIMAGE (2019)

Article Multidisciplinary Sciences

Machine learning for comprehensive forecasting of Alzheimer's Disease progression

Charles K. Fisher et al.

SCIENTIFIC REPORTS (2019)

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

Article Multidisciplinary Sciences

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Alexandra L. Young et al.

NATURE COMMUNICATIONS (2018)

Article Engineering, Electrical & Electronic

Alzheimer disease classification using KPCA, LDA, and multi-kernel learning SVM

Saruar Alam et al.

INTERNATIONAL JOURNAL OF IMAGING SYSTEMS AND TECHNOLOGY (2017)

Article Neurosciences

Instantiated mixed effects modeling of Alzheimer's disease markers

R. Guerrero et al.

NEUROIMAGE (2016)

Article Clinical Neurology

Estimating long-term multivariate progression from short-term data

Michael C. Donohue et al.

ALZHEIMERS & DEMENTIA (2014)

Article Clinical Neurology

A data-driven model of biomarker changes in sporadic Alzheimer's disease

Alexandra L. Young et al.

Article Clinical Neurology

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI

Leslie M. Shaw et al.

ACTA NEUROPATHOLOGICA (2011)

Article Clinical Neurology

How Should We Deal with Missing Data in Clinical Trials Involving Alzheimer's Disease Patients?

N. Coley et al.

CURRENT ALZHEIMER RESEARCH (2011)

Article Neurosciences

Quantifying the Pathophysiological Timeline of Alzheimer's Disease

Eric Yang et al.

JOURNAL OF ALZHEIMERS DISEASE (2011)

Review Clinical Neurology

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Clifford R. Jack et al.

LANCET NEUROLOGY (2010)

Article Neurosciences

Head size, age and gender adjustment in MRI studies: a necessary nuisance?

Josephine Barnes et al.

NEUROIMAGE (2010)

Article Geriatrics & Gerontology

Missing Data: A Special Challenge in Aging Research

Susan E. Hardy et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)

Article Clinical Neurology

Forecasting the global burden of Alzheimer's disease

Ron Brookmeyer et al.

ALZHEIMERS & DEMENTIA (2007)

Article Computer Science, Artificial Intelligence

Active appearance-based robot localization using stereo vision

JM Porta et al.

AUTONOMOUS ROBOTS (2005)